Display options
Cite
Yu Y, Pei M, Li L. Baicalin induces apoptosis in hepatic cancer cells in vitro and suppresses tumor growth in vivo. Int J Clin Exp Med. 2015;8(6):8958-67
Yu, Y., Pei, M., & Li, L. (2015). Baicalin induces apoptosis in hepatic cancer cells in vitro and suppresses tumor growth in vivo. International journal of clinical and experimental medicine, 8(6), 8958-67.
Yu, Yang, et al. "Baicalin induces apoptosis in hepatic cancer cells in vitro and suppresses tumor growth in vivo." International journal of clinical and experimental medicine vol. 8,6 (2015): 8958-67.
Yu Y, Pei M, Li L. Baicalin induces apoptosis in hepatic cancer cells in vitro and suppresses tumor growth in vivo. Int J Clin Exp Med. 2015 Jun 15;8(6):8958-67. eCollection 2015. PMID: 26309548; PMCID: PMC4538000.
Copy Download .nbib Format: NLM
Share it on

Int J Clin Exp Med. 2015 Jun 15;8(6):8958-67. eCollection 2015.

Baicalin induces apoptosis in hepatic cancer cells in vitro and suppresses tumor growth in vivo.

International journal of clinical and experimental medicine

Yang Yu, Mingyan Pei, Ling Li

Affiliations

  1. Department of Traditional Chinese Medicine, The First Affiliated Hospital of The General Hospital of The People's Liberation Army of China Beijing 100048, China.
  2. Department of Pharmacy, Heilongjiang Academy of Chinese Medicine Sciences Harbin 150036, Heilongjiang, China.
  3. Department of Pharmacy, Tongren Hospital, Shanghai Jiaotong University School of Medicine Shanghai 200336, China.

PMID: 26309548 PMCID: PMC4538000

Abstract

Baicalin is a flavonoid glycoside extracted from a kind of traditional Chinese drug, Scutellaria baicalensis, and possesses multiple pharmacological activities. The present study was designed to investigate the effects and mechanisms of baicalin against hepatic cancer cell growth and survival. We found that baicalin inhibited the viability and proliferation of two widely used hepatic cancer cell lines, Hep G2 and SMMC-7721 cells, in a dose-dependent manner. Cell cycle analysis revealed an increase in the S-phase cell population following 48 h exposure to baicalin. The expression levels of Cyclin A, CDK2, and Cyclin D1 were downregulated by baicalin treatment. Moreover, baicalin induced apoptotic cell death in Hep G2 and SMMC-7721 cells, which was accompanied by upregulation of Bax, downregulation of Bcl-2, and cleavages of Caspase-9, Caspase-3, and PARP. Furthermore, baicalin significantly inhibited the growth of xenografts in nude mice. In conclusion, we demonstrated for the first time that baicalin inhibited hepatic cancer cell growth and survival both in vitro and in vivo, suggesting that baicalin may be a potential phytochemical flavonoid for hepatic cancer therapy.

Keywords: Hepatic cancer; apoptosis; baicalin

References

  1. Acta Pharmacol Sin. 2009 Dec;30(12):1648-58 - PubMed
  2. Pharmacol Res. 2001 Feb;43(2):173-8 - PubMed
  3. N Engl J Med. 1995 May 11;332(19):1294-6 - PubMed
  4. Nat Prod Res. 2011 Jul;25(12):1150-60 - PubMed
  5. J Nat Med. 2012 Apr;66(2):311-20 - PubMed
  6. Curr Opin Genet Dev. 2007 Feb;17 (1):60-5 - PubMed
  7. Eur J Pharmacol. 2003 Mar 28;465(1-2):171-81 - PubMed
  8. Molecules. 2012 Mar 29;17(4):3844-57 - PubMed
  9. Science. 1998 Aug 28;281(5381):1312-6 - PubMed
  10. J Toxicol Sci. 2012;37(2):363-71 - PubMed
  11. Toxicol Lett. 2000 Jul 27;116(1-2):7-16 - PubMed
  12. BMC Cancer. 2014 Mar 21;14:217 - PubMed
  13. Cell Res. 2010 Nov;20(11):1252-62 - PubMed
  14. Nat Rev Mol Cell Biol. 2001 Jan;2(1):63-7 - PubMed
  15. Planta Med. 2002 Feb;68(2):128-32 - PubMed
  16. Curr Pharm Biotechnol. 2002 Sep;3(3):275-83 - PubMed
  17. Gastrointest Cancer Res. 2008 Mar;2(2):64-70 - PubMed
  18. Cell. 2005 Sep 23;122(6):825-7 - PubMed
  19. Prostate. 2001 Dec 1;49(4):285-92 - PubMed
  20. Exp Toxicol Pathol. 2013 Jan;65(1-2):189-96 - PubMed
  21. Cell. 1997 Nov 14;91(4):443-6 - PubMed
  22. Clin Transl Oncol. 2007 Dec;9(12):767-76 - PubMed
  23. Asian Pac J Cancer Prev. 2012;13(4):1119-24 - PubMed
  24. Brain Res Bull. 2011 Jul 15;85(6):396-402 - PubMed
  25. J Cell Sci. 2002 Jun 15;115(Pt 12):2461-4 - PubMed
  26. Toxicol Appl Pharmacol. 2011 Sep 15;255(3):316-26 - PubMed
  27. CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90 - PubMed
  28. FEBS Lett. 2000 Jan 21;466(1):6-10 - PubMed
  29. Arch Virol. 2011 May;156(5):793-801 - PubMed
  30. World J Gastroenterol. 2009 Oct 7;15(37):4720-5 - PubMed
  31. Nat Rev Mol Cell Biol. 2001 Jan;2(1):67-71 - PubMed
  32. J Histochem Cytochem. 2009 Apr;57(4):289-300 - PubMed
  33. J Exp Clin Cancer Res. 2012 May 20;31:48 - PubMed
  34. J Food Sci. 2010 Sep;75(7):H212-7 - PubMed

Publication Types